This study aimed to compare perinatal outcomes, including nonreassuring fetal
status, according to antenatal corticosteroid therapy (ACT) use during
late-preterm and early-term pregnancies. This was a retrospective cohort study of
women with singleton pregnancies who were at risk of late-preterm (34-36
Announcements
Open Access
Original Research
The association between antenatal corticosteroid use in late-preterm and early-term pregnancy and nonreassuring fetal status
Show Less
1
Department of Obstetrics and Gynecology, College of Medicine, Gyeongsang National University, Gyeongsang National University Changwon Hospital, 52828 Changwon, Republic of Korea
2
Department of Obstetrics and Gynecology, Hanmaeum Medical Center, 110-744 Changwon, Republic of Korea
3
Department of Obstetrics and Gynecology, College of Medicine, Gyeongsang National University Hospital, 52727 Jinju, Republic of Korea
*Correspondence: obgypjk@gnu.ac.kr (Ji Kwon Park)
Clin. Exp. Obstet. Gynecol. 2021, 48(1), 79–84;
https://doi.org/10.31083/j.ceog.2021.01.2250
Submitted: 4 August 2020 | Revised: 18 September 2020 | Accepted: 20 October 2020 | Published: 15 February 2021
Copyright: © 2021 The Authors. Published by IMR Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).
Abstract
Keywords
Antenatal corticosteroid
Late-preterm pregnancy
Early-term pregnancy
Nonreassuring fetal status
Transient tachypnea of the newborn
Figures
Fig. 1.